Forecast of Global Injectable Anticoagulants Players Market 2023

Global Injectable Anticoagulants Market will register a 2.7% CAGR in terms of revenue, reach US$ 6440 million by 2023, from US$ 5490 million in 2017. The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin®], enoxaparin [Lovenox®]) and factor Xa inhibitors (fondaparinux [Arixtra®]).